Hassan Fahmi

Titre : Professeur titulaire,                                        Département de médecine, Université de Montréal

Professeur accrédité,                               Département de pharmacologie et physiologie, Université de Montréal

Adresse : Centre de recherche du CHUM (CRCHUM)     Bureau R11.424                                                        900 rue St-Denis, Montréal, QC, H2X 0A9
Téléphone : 514 890-8000 # 25119
Courriel: h.fahmi@umontreal.ca


Formation    

  • PhD en Immunologie, Université Paris-Sud, Orsay;
  • Postdoctorat en Virologie, Institut Gustave Roussy, Villejuif;
  • Postdoctorat en Rhumatologie, Université de Montréal, Montréal.

Approches Techniques

Biochimie

Biologie Cellulaire

Biologie Moléculaire

Génétique,

Modèles animaux

Signalisation intracellulaire


Thèmes de recherche au laboratoire

  • Rôle des modifications épigénétiques dans la régulation de l’expression des gènes inflammatoires et cataboliques au niveau des tissus articulaires;
  • Étude du rôle des médiateurs lipidiques/eicosanoïdes dans la physiopathologie de l’arthrose;
  • Propriétés immunomodulatrices et anti-inflammatoires des cellules souches mésenchymateuses.

Publications

Kariminezhad Z, Rahimi M, Fernandes J, Maltais R, Sancéau JY, Poirier D, Fahmi H, Benderdour M. Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities. Antioxidants. 2024. 13(4), 386.

Najar M, Rahmani S, Faour WH, Alsabri SG, Lombard CA, Fayyad-Kazan H, Sokal EM, Merimi M, Fahmi H. Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway. Cells. 2024. 3(2):169.

Alsabri SG, Merimi M, Guedi GG, Najar M, Merimi M, Lavoie F, Grabs D, Fernandes J, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H. Epigenetic regulation of 15-lipoxygenase-1 expression in human chondrocytes by promoter methylation. Inflamm Res. 2023. 72(12):2145-2153

Najar M, Alsabri SG, Guedi GG, Merimi M, Lavoie F, Grabs D, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H. Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage. Front Cell Dev Biol. 2023. 30; 11:1256998.

Merimi M, Rahmani S, Afailal Tribak A, Bouhtit F, Fahmi H, Najar M. Fundamental and Applied Advances in Stem Cell Therapeutic Research. Cells. 2022 Cells. 2022 Jun 20;11(12):1976

Tardif G, Paré F, Gotti C, Roux-Dalvai F, Droit A, Zhai G, Sun G, Fahmi H, Pelletier JP, Martel-Pelletier J. Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers. Arthritis Res Ther. 2022 May 23;24(1):120

Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Agha D, Fahmi H, Lewalle P, Fayyad-kazan M, Merimi M. (2021). Therapeutic Mesenchymal Stem/StromalCells: Value, Challenges and Optimization. Front. Cell Dev. Biol. Front Cell Dev Biol. 2022 Jan 14; 9:716853.

Najar M, Merimi M, Faour W, Lombard C, Agha D, Ouhaddi Y, Sokal E, Lagneaux L, Fahmi H. (2021). Cellular and molecular interplay betweenforeskin-derived mesenchymal stromal / stem cell and the Th-17 cell pathway. 2021. Pharmaceutics. 2021. 19;13(10):1736.

Merimi M , El-Majzoub R, Lagneaux L, Agha D, Bouhtit F , Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M. The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. 2021. Front. Cell Dev. Biol.9: 661532.

Merimi M, Buyl K, Daassi D, Rodrigues R, Melki R, Lewalle P, Vanhaecke T, Fahmi H, Rogiers V, Lagneaux L, De Kock J, Najar M. (2021). Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging. 2021. Int J Mol Sci. 22(14): 7309.

Merimi M, Lewalle P, Meuleman N, Agha D, El-Kehdy H, Bouhtit F, Ayoub S, Burny A, Fahmi H, Lagneaux L, Najar M. Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic. J Clin Med. 2021 Feb 25; 10(5):905.

Najar M, Martel Pelletier J, Pelletier J-P, and Fahmi H. Novel insights for improving the therapeutic safety and efficiency of mesenchymal stromal cells. World J Stem Cells. 2020 Dec 26;12(12):1474-1491.

Ouhaddi Y, Najar M, Paré F, Lussier B, Urade Y, Benderdour M, Pelletier J-P, Martel Pelletier J, and Fahmi H. L-PGDS deficiency accelerated the development of naturally occurring age-related osteoarthritis. Aging. 2020 Dec 23;12(24):24778-24797.

Najar M, Martel Pelletier J, Pelletier J-P, and Fahmi H. Mesenchymal Stromal Cell Immunology for Efficient and Safe Therapeutic Effects in Osteoarthritis. Front Cell Dev Biol. 2020 Sep 22;8:567813.

Najar M, Merimi M, Faour W, Lombard C, Agha D, Ouhaddi Y, Sokal E, Lagneaux L, Fahmi H. (2021). Cellular and molecular interplay betweenforeskin-derived mesenchymal stromal / stem cell and the Th-17 cell pathway. 2021. Pharmaceutics. 2021. 19;13(10):1736.

Najar M, Ouhaddi Y, Paré P, Urade Y, Kapoor M, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H. Role Lipocalin-type prostaglandin D synthase in experimental osteoarthritis. Arthritis Rheumatol. 2020 Sep;72(9):1524-1533.